Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014
We report 20 cases of extensively drug-resistant tuberculosis managed in France. Treatment was individualized and included bedaquiline and linezolid for most patients and surgery in 8 patients. At last follow-up (22 months), 19 patients had achieved conversion from positive to negative on culture te...
Gespeichert in:
| Veröffentlicht in: | Emerging infectious diseases Jg. 22; H. 3; S. 518 - 521 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
U.S. National Center for Infectious Diseases
01.03.2016
Centers for Disease Control and Prevention |
| Schlagworte: | |
| ISSN: | 1080-6040, 1080-6059, 1080-6059 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | We report 20 cases of extensively drug-resistant tuberculosis managed in France. Treatment was individualized and included bedaquiline and linezolid for most patients and surgery in 8 patients. At last follow-up (22 months), 19 patients had achieved conversion from positive to negative on culture testing. These promising results of comprehensive management obtained in a small series deserve confirmation. |
|---|---|
| AbstractList | We report 20 cases of extensively drug-resistant tuberculosis managed in France. Treatment was individualized and included bedaquiline and linezolid for most patients and surgery in 8 patients. At last follow-up (22 months), 19 patients had achieved conversion from positive to negative on culture testing. These promising results of comprehensive management obtained in a small series deserve confirmation. We report 20 cases of extensively drug-resistant tuberculosis managed in France. Treatment was individualized and included bedaquiline and linezolid for most patients and surgery in 8 patients. At last follow-up (22 months), 19 patients had achieved conversion from positive to negative on culture testing. These promising results of comprehensive management obtained in a small series deserve confirmation.We report 20 cases of extensively drug-resistant tuberculosis managed in France. Treatment was individualized and included bedaquiline and linezolid for most patients and surgery in 8 patients. At last follow-up (22 months), 19 patients had achieved conversion from positive to negative on culture testing. These promising results of comprehensive management obtained in a small series deserve confirmation. |
| Audience | Professional Academic |
| Author | Bellaud, Guillaume Véziris, Nicolas Jauréguiberry, Stéphane Dournon, Nathalie Le Dû, Damien Henry, Benoît Caumes, Éric Tattevin, Pierre Morel, Sébastien Revest, Matthieu Epelboin, Loïc Mordant, Pierre Bricaire, François Michelet, Christian Mellon, Guillaume Bernard, Christine |
| Author_xml | – sequence: 1 givenname: Benoît surname: Henry fullname: Henry, Benoît – sequence: 2 givenname: Matthieu surname: Revest fullname: Revest, Matthieu – sequence: 3 givenname: Nathalie surname: Dournon fullname: Dournon, Nathalie – sequence: 4 givenname: Loïc surname: Epelboin fullname: Epelboin, Loïc – sequence: 5 givenname: Guillaume surname: Mellon fullname: Mellon, Guillaume – sequence: 6 givenname: Guillaume surname: Bellaud fullname: Bellaud, Guillaume – sequence: 7 givenname: Pierre surname: Mordant fullname: Mordant, Pierre – sequence: 8 givenname: Damien surname: Le Dû fullname: Le Dû, Damien – sequence: 9 givenname: Nicolas surname: Véziris fullname: Véziris, Nicolas – sequence: 10 givenname: Christine surname: Bernard fullname: Bernard, Christine – sequence: 11 givenname: Sébastien surname: Morel fullname: Morel, Sébastien – sequence: 12 givenname: Stéphane surname: Jauréguiberry fullname: Jauréguiberry, Stéphane – sequence: 13 givenname: Christian surname: Michelet fullname: Michelet, Christian – sequence: 14 givenname: François surname: Bricaire fullname: Bricaire, François – sequence: 15 givenname: Pierre surname: Tattevin fullname: Tattevin, Pierre – sequence: 16 givenname: Éric surname: Caumes fullname: Caumes, Éric |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26891089$$D View this record in MEDLINE/PubMed https://hal.sorbonne-universite.fr/hal-01294307$$DView record in HAL |
| BookMark | eNqNk89u1DAQxiNURP_AlSOKhISo1F3sxLHjC1JVWrpSq6K2cLUcZ5x1lbWL7azaE7wDb8iT4GWX0q2KhHJIMv5938zYnu1swzoLWfYSo3FZIPwOTFsUqBzjCuMSPcm2MKrRiKKKb9x9E7SZbYdwhRBOEv4s2yxozdMi38q-ffLQm5mx0t_mR3LuvGx6yM-GqNwMcu18fgqtUbLvb3Np2_xi8N3q91Ra2UGbH95EsMHMIcU--KEbnUMwIUob88uhAa-G3qXAXn7kpVWwlxcI8Z_ff6RiyPPsqZZ9gBer9072-ejw8uB4dHL2cXKwfzJSlJM40kULSOmSVEAAMYTqiupSs5oySgvcNLqoWsY11pxQoEjSuiq0pBTxRmFVljvZZOnbOnklrr2ZpYaFk0b8DjjfCemjUT2IkqO6aJjELU75KtpohhUrypZWiOiaJK_3S6_roZlBq8BGL_s10_UVa6aic3NBUrF1vShmd2kwfSA73j8Ri1g6KE5KxOY4sW9Xybz7OkCIYmaCgr6XFtwQBGaUIcYwW9i-XqKdTG0Yq13Krha42CeEY14xXCRq9AjVgYVUarpc2qTwGj9-hE9PCzOjHhXsrgkSE-EmdnIIQUwuzv-fPfuyzr65x05B9nEaXD9E42xYB1_dP5-7Hf5z6_-2pLwLwYO-QzASi7ESq7ESy7FKAvJAoEyUi8RpL0z_L9kvyCcgqQ |
| CitedBy_id | crossref_primary_10_1128_microbiolspec_TNMI7_0043_2017 crossref_primary_10_1183_13993003_01462_2017 crossref_primary_10_1183_13993003_01799_2016 crossref_primary_10_3201_eid2608_191499 crossref_primary_10_1093_jtm_taab069 crossref_primary_10_15446_av_enferm_v35n3_62733 |
| Cites_doi | 10.1001/jama.300.18.2153 10.1016/S0140-6736(13)62675-6 10.1371/journal.pone.0054587 10.1136/thx.2008.108712 10.1371/journal.pone.0053466 10.5588/ijtld.14.0944 10.1016/j.socscimed.2004.08.046 10.1007/s10096-010-1096-7 10.2807/1560-7917.ES2013.18.33.20555 10.1086/590009 10.1371/journal.pone.0063057 10.1056/NEJMoa1313865 10.1086/653115 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2016 U.S. National Center for Infectious Diseases licence_http://creativecommons.org/publicdomain/zero |
| Copyright_xml | – notice: COPYRIGHT 2016 U.S. National Center for Infectious Diseases – notice: licence_http://creativecommons.org/publicdomain/zero |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 7X8 1XC VOOES 5PM DOA |
| DOI | 10.3201/eid2203.151130 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| DocumentTitleAlternate | Medically and Surgically Managed XDR TB, France |
| EISSN | 1080-6059 |
| EndPage | 521 |
| ExternalDocumentID | oai_doaj_org_article_39082b7a1d134556bf71c723d6504f84 PMC4766883 oai:HAL:hal-01294307v1 A449195712 26891089 10_3201_eid2203_151130 |
| Genre | Historical Article Journal Article |
| GeographicLocations | France |
| GeographicLocations_xml | – name: France |
| GroupedDBID | --- -~X .GJ 186 29G 2WC 36B 53G 5GY 5VS 6PF 7RV 7X7 85S 8C1 8FI 8FJ 9K5 A8Z AAWTL AAYXX ABDBF ABUWG ACGFO ACUHS ADBBV ADRAZ AEGXH AENEX AETEA AEUYN AFFHD AFKRA AIAGR ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC B0M BAIFH BANNL BAWUL BBTPI BCNDV BENPR C1A CCPQU CITATION DIK DO4 E3Z EAD EAP EAS EBC EBD EBS EDH EJD EMB EMH EMI EMK EMOBN EPL EPT ESX F5P FRP FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IBB IEA IEP IHR IHW IMI INH INR IOF IOV IPO ISR ITC K9- KQ8 M0R M48 NAPCQ NEJ O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PJZUB PPXIY PV9 Q.E QF4 QM9 QN7 QO4 Q~Q RGD RGQ RNS RPM RXW RZL SV3 TAE TR2 TUS TWZ UKHRP UQL W2D WH7 WOQ WOW XSB YRT YV5 YXF ZBA ZGI ~8M ALIPV CGR CUY CVF ECM EIF NPM XJT 7X8 ESTFP 1XC VOOES 5PM |
| ID | FETCH-LOGICAL-c694t-f2de0cf345e4e0700856f3f78676621bbf25d79f1f946e60a6852fa6609bc1c33 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 8 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000371192100023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1080-6040 1080-6059 |
| IngestDate | Fri Oct 03 12:33:39 EDT 2025 Tue Nov 04 01:58:58 EST 2025 Sat Nov 29 06:30:41 EST 2025 Wed Oct 01 14:44:59 EDT 2025 Mon Nov 24 16:07:23 EST 2025 Mon Nov 24 15:51:00 EST 2025 Sun Nov 23 08:47:48 EST 2025 Wed Nov 26 09:38:42 EST 2025 Wed Nov 26 09:49:00 EST 2025 Thu May 22 21:24:09 EDT 2025 Mon Jul 21 06:02:20 EDT 2025 Tue Nov 18 19:54:07 EST 2025 Sat Nov 29 02:37:34 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | bacteria XDR TB tuberculosis multidrug-resistant tuberculosis bedaquiline TB thoracic surgery antimicrobial resistance extensively drug-resistant tuberculosis tuberculosis and other mycobacteria MDR TB France outcome |
| Language | English |
| License | licence_http://creativecommons.org/publicdomain/zero/: http://creativecommons.org/publicdomain/zero This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c694t-f2de0cf345e4e0700856f3f78676621bbf25d79f1f946e60a6852fa6609bc1c33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-3481-5991 0000-0001-5660-6544 |
| OpenAccessLink | https://doaj.org/article/39082b7a1d134556bf71c723d6504f84 |
| PMID | 26891089 |
| PQID | 1767077173 |
| PQPubID | 23479 |
| PageCount | 4 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_39082b7a1d134556bf71c723d6504f84 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4766883 hal_primary_oai_HAL_hal_01294307v1 proquest_miscellaneous_1767077173 gale_infotracmisc_A449195712 gale_infotracgeneralonefile_A449195712 gale_infotracacademiconefile_A449195712 gale_incontextgauss_ISR_A449195712 gale_incontextgauss_IOV_A449195712 gale_healthsolutions_A449195712 pubmed_primary_26891089 crossref_primary_10_3201_eid2203_151130 crossref_citationtrail_10_3201_eid2203_151130 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-03-00 2016-Mar 20160301 2016-03 2016-03-01 |
| PublicationDateYYYYMMDD | 2016-03-01 |
| PublicationDate_xml | – month: 03 year: 2016 text: 2016-03-00 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Emerging infectious diseases |
| PublicationTitleAlternate | Emerg Infect Dis |
| PublicationYear | 2016 |
| Publisher | U.S. National Center for Infectious Diseases Centers for Disease Control and Prevention |
| Publisher_xml | – name: U.S. National Center for Infectious Diseases – name: Centers for Disease Control and Prevention |
| References | Jacobson (key-10.3201/eid2203.151130-201602180845-R1) 2010; 51 Jeon (key-10.3201/eid2203.151130-201602180845-R10) 2009; 13 key-10.3201/eid2203.151130-201602180845-R3 Yong Kim (key-10.3201/eid2203.151130-201602180845-R15) 2005; 61 Minion (key-10.3201/eid2203.151130-201602180845-R9) 2013; 8 Bernard (key-10.3201/eid2203.151130-201602180845-R2) 2013; 18 Pooran (key-10.3201/eid2203.151130-201602180845-R14) 2013; 8 Pietersen (key-10.3201/eid2203.151130-201602180845-R5) 2014; 383 Abubakar (key-10.3201/eid2203.151130-201602180845-R6) 2009; 64 Banerjee (key-10.3201/eid2203.151130-201602180845-R7) 2008; 47 Ndjeka (key-10.3201/eid2203.151130-201602180845-R13) 2015; 19 Diacon (key-10.3201/eid2203.151130-201602180845-R11) 2014; 371 Shean (key-10.3201/eid2203.151130-201602180845-R12) 2013; 8 Shah (key-10.3201/eid2203.151130-201602180845-R4) 2008; 300 Bendayan (key-10.3201/eid2203.151130-201602180845-R8) 2011; 30 19383192 - Int J Tuberc Lung Dis. 2009 May;13(5):594-600 19318348 - Thorax. 2009 Jun;64(6):512-5 20972692 - Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):375-9 15896895 - Soc Sci Med. 2005 Aug;61(4):847-59 23968874 - Euro Surveill. 2013;18(33):20555 18616396 - Clin Infect Dis. 2008 Aug 15;47(4):450-7 20504231 - Clin Infect Dis. 2010 Jul 1;51(1):6-14 26162365 - Int J Tuberc Lung Dis. 2015 Aug;19(8):979-85 23349933 - PLoS One. 2013;8(1):e54587 23667572 - PLoS One. 2013;8(5):e63057 19001626 - JAMA. 2008 Nov 12;300(18):2153-60 25140958 - N Engl J Med. 2014 Aug 21;371(8):723-32 24439237 - Lancet. 2014 Apr 5;383(9924):1230-9 23326436 - PLoS One. 2013;8(1):e53466 |
| References_xml | – volume: 300 start-page: 2153 year: 2008 ident: key-10.3201/eid2203.151130-201602180845-R4 article-title: Extensively drug-resistant tuberculosis in the United States, 1993–2007. publication-title: JAMA doi: 10.1001/jama.300.18.2153 – volume: 383 start-page: 1230 year: 2014 ident: key-10.3201/eid2203.151130-201602180845-R5 article-title: Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study. publication-title: Lancet doi: 10.1016/S0140-6736(13)62675-6 – volume: 8 start-page: e54587 year: 2013 ident: key-10.3201/eid2203.151130-201602180845-R14 article-title: What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa? publication-title: PLoS ONE doi: 10.1371/journal.pone.0054587 – ident: key-10.3201/eid2203.151130-201602180845-R3 – volume: 64 start-page: 512 year: 2009 ident: key-10.3201/eid2203.151130-201602180845-R6 article-title: Extensively drug-resistant tuberculosis in the UK: 1995 to 2007. publication-title: Thorax doi: 10.1136/thx.2008.108712 – volume: 8 start-page: e53466 year: 2013 ident: key-10.3201/eid2203.151130-201602180845-R9 article-title: Multidrug and extensively drug-resistant tuberculosis in Canada 1997–2008: demographic and disease characteristics. publication-title: PLoS ONE doi: 10.1371/journal.pone.0053466 – volume: 19 start-page: 979 year: 2015 ident: key-10.3201/eid2203.151130-201602180845-R13 article-title: Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis. publication-title: Int J Tuberc Lung Dis doi: 10.5588/ijtld.14.0944 – volume: 61 start-page: 847 year: 2005 ident: key-10.3201/eid2203.151130-201602180845-R15 article-title: Limited good and limited vision: multidrug-resistant tuberculosis and global health policy. publication-title: Soc Sci Med doi: 10.1016/j.socscimed.2004.08.046 – volume: 30 start-page: 375 year: 2011 ident: key-10.3201/eid2203.151130-201602180845-R8 article-title: Outcome of hospitalized MDR-TB patients: Israel 2000–2005. publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-010-1096-7 – volume: 18 start-page: 20555 year: 2013 ident: key-10.3201/eid2203.151130-201602180845-R2 article-title: A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union. publication-title: Euro Surveill doi: 10.2807/1560-7917.ES2013.18.33.20555 – volume: 47 start-page: 450 year: 2008 ident: key-10.3201/eid2203.151130-201602180845-R7 article-title: Extensively drug-resistant tuberculosis in California, 1993–2006. publication-title: Clin Infect Dis doi: 10.1086/590009 – volume: 13 start-page: 594 year: 2009 ident: key-10.3201/eid2203.151130-201602180845-R10 article-title: Survival and predictors of outcomes in non-HIV–infected patients with extensively drug-resistant tuberculosis. publication-title: Int J Tuberc Lung Dis – volume: 8 start-page: e63057 year: 2013 ident: key-10.3201/eid2203.151130-201602180845-R12 article-title: Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa. publication-title: PLoS ONE doi: 10.1371/journal.pone.0063057 – volume: 371 start-page: 723 year: 2014 ident: key-10.3201/eid2203.151130-201602180845-R11 article-title: Multidrug-resistant tuberculosis and culture conversion with bedaquiline. publication-title: N Engl J Med doi: 10.1056/NEJMoa1313865 – volume: 51 start-page: 6 year: 2010 ident: key-10.3201/eid2203.151130-201602180845-R1 article-title: Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis. publication-title: Clin Infect Dis doi: 10.1086/653115 – reference: 18616396 - Clin Infect Dis. 2008 Aug 15;47(4):450-7 – reference: 19001626 - JAMA. 2008 Nov 12;300(18):2153-60 – reference: 20972692 - Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):375-9 – reference: 23326436 - PLoS One. 2013;8(1):e53466 – reference: 25140958 - N Engl J Med. 2014 Aug 21;371(8):723-32 – reference: 20504231 - Clin Infect Dis. 2010 Jul 1;51(1):6-14 – reference: 24439237 - Lancet. 2014 Apr 5;383(9924):1230-9 – reference: 19318348 - Thorax. 2009 Jun;64(6):512-5 – reference: 23968874 - Euro Surveill. 2013;18(33):20555 – reference: 26162365 - Int J Tuberc Lung Dis. 2015 Aug;19(8):979-85 – reference: 23349933 - PLoS One. 2013;8(1):e54587 – reference: 23667572 - PLoS One. 2013;8(5):e63057 – reference: 19383192 - Int J Tuberc Lung Dis. 2009 May;13(5):594-600 – reference: 15896895 - Soc Sci Med. 2005 Aug;61(4):847-59 |
| SSID | ssj0012019 |
| Score | 2.2357333 |
| Snippet | We report 20 cases of extensively drug-resistant tuberculosis managed in France. Treatment was individualized and included bedaquiline and linezolid for most... |
| SourceID | doaj pubmedcentral hal proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 518 |
| SubjectTerms | Adult Antitubercular agents Antitubercular Agents - pharmacology Antitubercular Agents - therapeutic use Combined Modality Therapy Dispatch Drug therapy extensively drug-resistant tuberculosis Extensively Drug-Resistant Tuberculosis - epidemiology Extensively Drug-Resistant Tuberculosis - history Extensively Drug-Resistant Tuberculosis - therapy Female Follow-Up Studies France - epidemiology History, 21st Century Human health and pathology Humans Life Sciences Male MDR TB Microbial drug resistance multidrug-resistant tuberculosis Mycobacterium tuberculosis - drug effects Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014 Treatment Outcome Tuberculosis XDR TB |
| Title | Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014 |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/26891089 https://www.proquest.com/docview/1767077173 https://hal.sorbonne-universite.fr/hal-01294307 https://pubmed.ncbi.nlm.nih.gov/PMC4766883 https://doaj.org/article/39082b7a1d134556bf71c723d6504f84 |
| Volume | 22 |
| WOSCitedRecordID | wos000371192100023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1080-6059 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0012019 issn: 1080-6040 databaseCode: DOA dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLbYxAMSQtwJjGEQYi_LFjuuL48FVg1p2qZtTH2znMTuKlUpSpuKPcF_4B_ySziO06rhInjgse7XNj3n5Pg4_vwdhF5zU2Q9Ij2twvKYWUNjlScsNiTNrVRUyKY34OWROD6Ww6E6XWv15TlhQR44GG4_9T25M2FIQVLW6_HMCZILmhZQWjAnGyVQqHqWi6l2_wCmNRWo9bA4gjgNco0pDO_bcUFpku7BVEc893ltOmpU-1e5eePKUyN_rTt_pk-uzUeDu-hOW0jifvgD99ANW95Ht8NTOBwOFz1AX04rO2n6dlXXeGAW4O9sYvFJPYdAsxgKVtzu1EyusSkLfF5Xo_ZlIMYU-OBzS3KHsfdVPYrP7MwXneUcX9SZrfJ6MoWBXdz06LC72O-EfP_6DazAHqKPg4OLd4dx23Ihzrli89jRwia5A0tbZiEbQEHGXeqE5IJzSrLM0V4hlCNOMW55YrjsUWc4T1SWkzxNH6HNclraJwgr5mDig9WIF0kjmcuKIjVZkYLVLTUsiVC8tLzOWz1y3xZjomFd4j2lW0_p4KkI7azwn4ISxx-Rb70jVyivoN0MQFzpNq703-IqQi98GOhwHHWVB3SfMUVUTxAaoVcNwqtolJ6mMzL1bKY_nFz-A-j8rAPaaUFuCibITXs0Agzp1bk6yDcd5Chok_8OuNUBQtLIu5cF0d2x0GH_SPsx_2SSQeZfkAi9XAa_9p_3dLzSTuuZJoKLRHgCR4Qeh5th9V2USyhBpYqQ6NwmnR_rvlOOrxphcwZBJmX69H_47xm6BZHBA11wC23Oq9o-RzfzxXw8q7bRhhjK7SZn_AD1yGkX |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preliminary+Favorable+Outcome+for+Medically+and+Surgically+Managed+Extensively+Drug-Resistant+Tuberculosis%2C+France%2C+2009-2014&rft.jtitle=Emerging+infectious+diseases&rft.au=Henry%2C+Beno%C3%AEt&rft.au=Revest%2C+Matthieu&rft.au=Dournon%2C+Nathalie&rft.au=Epelboin%2C+Lo%C3%AFc&rft.date=2016-03-01&rft.pub=Centers+for+Disease+Control+and+Prevention&rft.issn=1080-6040&rft.eissn=1080-6059&rft.volume=22&rft.issue=3&rft.spage=518&rft.epage=521&rft_id=info:doi/10.3201%2Feid2203.151130&rft_id=info%3Apmid%2F26891089&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=oai%3AHAL%3Ahal-01294307v1 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1080-6040&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1080-6040&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1080-6040&client=summon |